Skip to main content
. 2021 Sep 8;13:689939. doi: 10.3389/fnagi.2021.689939

FIGURE 1.

FIGURE 1

Serum PACAP and VIP levels in Parkinson’s disease (PD) patients and in healthy controls. (A) Lower serum PACAP levels were detected in PD patients than in healthy controls. (B) Lower serum VIP levels were detected in PD patients than in healthy controls. Values are presented as the mean ± standard deviation. ∗∗∗P < 0.001. PACAP, pituitary adenylate cyclase-activating polypeptide; VIP, vasoactive intestinal peptide.